{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:41:15Z","timestamp":1769208075455,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106155","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T18:01:50Z","timestamp":1409162510000},"page":"e106155","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["A Critical Role for the mTORC2 Pathway in Lung Fibrosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Wenteh","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn D.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"ref1","first-page":"3","article-title":"Pulmonary fibrosis","volume":"117","author":"DA Zisman","year":"2005","journal-title":"Methods Mol Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1513\/pats.200602-021TK","article-title":"Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls","volume":"3","author":"K Ask","year":"2006","journal-title":"Proceedings of the American Thoracic Society"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"ra64","DOI":"10.1126\/scisignal.2000998","article-title":"Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases","volume":"3","author":"A Moritz","year":"2010","journal-title":"Sci Signal"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2009.10.011","article-title":"Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth","volume":"36","author":"JJ Gibbons","year":"2009","journal-title":"Semin Oncol"},{"key":"ref5","first-page":"638","article-title":"Novel inhibitors of mTORC1 and mTORC2","volume":"11","author":"SV Bhagwat","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","article-title":"mTOR complex 2 signaling and functions","volume":"10","author":"WJ Oh","year":"2011","journal-title":"Cell Cycle"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/BST0370227","article-title":"mTORC1 signalling and mRNA translation","volume":"37","author":"CG Proud","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"DD Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Li Y, Wang X, Yue P, Tao H, Ramalingam SS, <etal>et al<\/etal>.. (2013) Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation. The Journal of biological chemistry.","DOI":"10.1074\/jbc.M113.463679"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1440-1843.2011.01955.x","article-title":"An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis","volume":"16","author":"MA Malouf","year":"2011","journal-title":"Respirology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"DD Sarbassov","year":"2005","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1074\/jbc.M109.025684","article-title":"SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin","volume":"285","author":"W Chang","year":"2010","journal-title":"The Journal of biological chemistry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.2353\/ajpath.2010.091117","article-title":"Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis","volume":"176","author":"H Xia","year":"2010","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Huang SK, White ES, Wettlaufer SH, Grifka H, Hogaboam CM, <etal>et al<\/etal>.. (2009) Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J.","DOI":"10.1096\/fj.08-128801"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/leu.2012.276","article-title":"Efficacy of the investigational mTOR kinase inhibitor MLN0128\/INK128 in models of B-cell acute lymphoblastic leukemia","volume":"27","author":"MR Janes","year":"2013","journal-title":"Leukemia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10549-012-2298-8","article-title":"Investigational drug MLN0128, a novel TORC1\/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models","volume":"136","author":"Y Gokmen-Polar","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10549-014-2877-y","article-title":"mTORC1\/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms","volume":"144","author":"KA Wilson-Edell","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1074\/jbc.M009713200","article-title":"Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway","volume":"276","author":"WT Chang","year":"2001","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0002-9440(10)64046-1","article-title":"PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis","volume":"158","author":"G Krishna","year":"2001","journal-title":"Am J Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"T Ashcroft","year":"1988","journal-title":"J Clin Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay","volume":"170","author":"SA Ahmed","year":"1994","journal-title":"Journal of immunological methods"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/abio.1997.2391","article-title":"A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases","volume":"253","author":"M Zhou","year":"1997","journal-title":"Analytical biochemistry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/onc.2012.30","article-title":"Role of the integrin-linked kinase (ILK)\/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT)","volume":"32","author":"I Serrano","year":"2013","journal-title":"Oncogene"},{"key":"ref24","first-page":"428","article-title":"Recent advances in the development of selective, ATP-competitive inhibitors of mTOR","volume":"13","author":"DJ Richard","year":"2010","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","article-title":"Janes MR, Limon JJ, So L, Chen J, Lim RJ, et al. Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor","volume":"16","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Guo Y, Kwiatkowski DJ (2013) Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis. Molecular cancer research: MCR.","DOI":"10.1158\/1541-7786.MCR-12-0605"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and role of let-7d in idiopathic pulmonary fibrosis","volume":"182","author":"KV Pandit","year":"2010","journal-title":"American journal of respiratory and critical care medicine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1096\/fj.04-2882fje","article-title":"Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts","volume":"19","author":"M Waghray","year":"2005","journal-title":"FASEB J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-6-6","article-title":"Secreted protein acidic and rich in cysteine (SPARC) is upregulated by transforming growth factor (TGF)-beta and is required for TGF-beta-induced hydrogen peroxide production in fibroblasts","volume":"6","author":"S Shibata","year":"2013","journal-title":"Fibrogenesis & tissue repair"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Goncharov DA, Kudryashova TV, Ziai H, Ihida-Stansbury K, Delisser H, <etal>et al<\/etal>.. (2013) mTORC2 Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation and Survival in Pulmonary Arterial Hypertension. Circulation.","DOI":"10.1161\/CIRCULATIONAHA.113.004581"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"DA Guertin","year":"2006","journal-title":"Dev Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","article-title":"FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor","volume":"18","author":"CC Chen","year":"2010","journal-title":"Dev Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.molcel.2013.09.018","article-title":"The translational landscape of the Mammalian cell cycle","volume":"52","author":"CR Stumpf","year":"2013","journal-title":"Mol Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e80300","DOI":"10.1371\/journal.pone.0080300","article-title":"MiR-424\/503-Mediated Rictor Upregulation Promotes Tumor Progression","volume":"8","author":"C Oneyama","year":"2013","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ncb2507","article-title":"PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of Galpha12","volume":"14","author":"X Gan","year":"2012","journal-title":"Nature cell biology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"AM Tager","year":"2008","journal-title":"Nature medicine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/CAD.0b013e32833760bf","article-title":"Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma","volume":"21","author":"J Rodriguez-Pascual","year":"2010","journal-title":"Anticancer Drugs"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.transproceed.2011.11.059","article-title":"Sirolimus-induced pneumonitis after renal transplantation: a single-center experience","volume":"44","author":"HS Lee","year":"2012","journal-title":"Transplantation proceedings"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ajpath.2012.08.006","article-title":"Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1\/2 inhibitor","volume":"181","author":"F Syed","year":"2012","journal-title":"The American journal of pathology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e59348","DOI":"10.1371\/journal.pone.0059348","article-title":"Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for \u201cactive\u201d disease","volume":"8","author":"R Peng","year":"2013","journal-title":"PLoS ONE"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"TE King Jr","year":"2014","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"L Richeldi","year":"2014","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:40:20Z","timestamp":1589035220000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106155"}},"subtitle":[],"editor":[{"given":"Ana","family":"Mora","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106155","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}